KLP Kapitalforvaltning’s Avadel Pharmaceuticals AVDL Stock Holding History

KLP Kapitalforvaltning’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,600	Closed	-$401K	–	2161
2025 Q4	$401K	Buy	18,600 +1,600	+9%	+$31.1K	﹤0.01%	1519
2025 Q3	$260K	Hold	17,000	–	–	﹤0.01%	1707
2025 Q2	$150K	Sell	17,000 -3,700	-18%	-$32.5K	﹤0.01%	1889
2025 Q1	$162K	Hold	20,700	–	–	﹤0.01%	1839
2024 Q4	$218K	Buy	+20,700	New	+$251K	﹤0.01%	1783

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

KLP Kapitalforvaltning's AVDL Position: Q1 2026 in Review

KLP Kapitalforvaltning sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 18,600 shares — an estimated $401K sold.

KLP Kapitalforvaltning first reported a position in AVDL in Q4 2024 and held it in 5 quarters. The position peaked at $401K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

KLP Kapitalforvaltning reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
KLP Kapitalforvaltning sold 18,600 Avadel Pharmaceuticals shares in Q1 2026, an estimated $401K.
KLP Kapitalforvaltning first reported a position in Avadel Pharmaceuticals in Q4 2024 and held it in 5 quarters.
KLP Kapitalforvaltning's Avadel Pharmaceuticals position peaked at $401K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.